Clinical Trial: Venetoclax Combined With Azactidine in the Treatment of ALAL
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Leukemia of Ambiguous Lineage
Study Type: INTERVENTIONAL
Official Title: A Multicenter Prospective Clinical Study of Venetoclax Combined With Azactidine in the Treatment of Acute Leukaemias of Ambiguous Lineage
Brief Summary:
The prognosis of acute leukaemias of ambiguous lineage is poor.The effect of chemotherapy regimen and hematopoietic stem cell transplantation are still unclear.Therefore, we will explore new therapy to improve the remission rate of acute leukaemias of ambiguous lineage.Venetoclax can significantly improve the remission rate and prolong PFS and OS.At present, venetoclax combined with azacitidine or decitabine has become the preferred treatment regimen for elderly AML patients.It also shows a high response rate in…
Read more